Tommasino M - Search Results

1

Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions.

Zehbe I, Rätsch A, Alunni-Fabbroni M, Burzlaff A, Bakos E, Dürst M, Wilander E, Tommasino M. Zehbe I, et al. Among authors: tommasino m. Oncogene. 1999 Apr 1;18(13):2201-11. doi: 10.1038/sj.onc.1202549. Oncogene. 1999. PMID: 10327066

2

Identification of a novel activity of human papillomavirus type 16 E6 protein in deregulating the G1/S transition.

Malanchi I, Caldeira S, Krützfeldt M, Giarre M, Alunni-Fabbroni M, Tommasino M. Malanchi I, et al. Among authors: tommasino m. Oncogene. 2002 Aug 22;21(37):5665-72. doi: 10.1038/sj.onc.1205617. Oncogene. 2002. PMID: 12173036

3

Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.

Alunni-Fabbroni M, Littlewood T, Deleu L, Caldeira S, Giarrè M, Dell' Orco M, Tommasino M. Alunni-Fabbroni M, et al. Among authors: tommasino m. Oncogene. 2000 May 4;19(19):2277-85. doi: 10.1038/sj.onc.1203570. Oncogene. 2000. PMID: 10822378

4

p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.

Zehbe I, Voglino G, Wilander E, Delius H, Marongiu A, Edler L, Klimek F, Andersson S, Tommasino M. Zehbe I, et al. Among authors: tommasino m. Cancer Res. 2001 Jan 15;61(2):608-11. Cancer Res. 2001. PMID: 11212257

5

Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype.

Zehbe I, Wilander E, Delius H, Tommasino M. Zehbe I, et al. Among authors: tommasino m. Cancer Res. 1998 Feb 15;58(4):829-33. Cancer Res. 1998. PMID: 9485042

6

The role of TP53 in Cervical carcinogenesis.

Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A, Zehbe I. Tommasino M, et al. Hum Mutat. 2003 Mar;21(3):307-12. doi: 10.1002/humu.10178. Hum Mutat. 2003. PMID: 12619117 Review.

7

Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes.

Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, Marongiu A, Gissmann L, Wilander E, Tommasino M. Zehbe I, et al. Among authors: tommasino m. Int J Cancer. 2001 Dec 1;94(5):711-6. doi: 10.1002/ijc.1520. Int J Cancer. 2001. PMID: 11745467

8

The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties.

Caldeira S, Zehbe I, Accardi R, Malanchi I, Dong W, Giarrè M, de Villiers EM, Filotico R, Boukamp P, Tommasino M. Caldeira S, et al. Among authors: tommasino m. J Virol. 2003 Feb;77(3):2195-206. doi: 10.1128/jvi.77.3.2195-2206.2003. J Virol. 2003. PMID: 12525654 Free PMC article.

9

Codon 72 polymorphism of p53 and its association with cervical cancer.

Zehbe I, Voglino G, Wilander E, Genta F, Tommasino M. Zehbe I, et al. Among authors: tommasino m. Lancet. 1999 Jul 17;354(9174):218-9. doi: 10.1016/S0140-6736(99)01914-5. Lancet. 1999. PMID: 10421306

10

Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein.

Caldeira S, de Villiers EM, Tommasino M. Caldeira S, et al. Among authors: tommasino m. Oncogene. 2000 Feb 10;19(6):821-6. doi: 10.1038/sj.onc.1203375. Oncogene. 2000. PMID: 10698500

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters